Multiple target therapy may treat HER2-positive breast cancers

[News]

Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies by Vanderbilt-Ingram Cancer Center investigators.

More... (http://www.news-medical.net/news/20110309/Multiple-target-therapy-may-treat-HER2-positive-breast-cancers.aspx)